Literature DB >> 25440029

Dilemma of stage II colon cancer and decision making for adjuvant chemotherapy.

Sandy H Fang1, Jonathan E Efron1, Mariana E Berho2, Steven D Wexner3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25440029     DOI： 10.1016/j.jamcollsurg.2014.09.010

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  16 in total

1.  Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.

Authors:  Noemi Eiro; Juan Francisco Carrión; Sandra Cid; Alejandro Andicoechea; José Luis García-Muñiz; Luis O González; Francisco J Vizoso
Journal:  Pathol Oncol Res       Date:  2019-02-01       Impact factor: 3.201

2.  Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.

Authors:  Raju Kandimalla; Feng Gao; Ajay Goel; Takatoshi Matsuyama; Toshiaki Ishikawa; Hiroyuki Uetake; Naoki Takahashi; Yasuhide Yamada; Carlos Becerra; Scott Kopetz; Xin Wang
Journal:  Clin Cancer Res       Date:  2018-03-07       Impact factor: 12.531

3.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.

Authors:  Piero Dalerba; Debashis Sahoo; Soonmyung Paik; Xiangqian Guo; Greg Yothers; Nan Song; Nate Wilcox-Fogel; Erna Forgó; Pradeep S Rajendran; Stephen P Miranda; Shigeo Hisamori; Jacqueline Hutchison; Tomer Kalisky; Dalong Qian; Norman Wolmark; George A Fisher; Matt van de Rijn; Michael F Clarke
Journal:  N Engl J Med       Date:  2016-01-21       Impact factor: 91.245

4.  Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.

Authors:  Aslam Ejaz; Leigh Casadaban; Ajay V Maker
Journal:  J Surg Res       Date:  2017-03-31       Impact factor: 2.192

5.  Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma.

Authors:  Jia Huang; Yiwei Zhang; Jia Zhou; Min Fang; Xiaofeng Wu; Yuhang Luo; Qiulin Huang; Yujuan Ouyang; Shuai Xiao
Journal:  Int J Colorectal Dis       Date:  2022-09-23       Impact factor: 2.796

6.  High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.

Authors:  Ji Soo Park; Hong Jae Chon; Hei-Cheul Jeung; Sang Joon Shin; Sun Young Rha; Joong Bae Ahn; Kang Young Lee; Nam Kyu Kim; Hyun Cheol Chung
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-22       Impact factor: 4.553

Review 7.  Assessment of lymph node involvement in colorectal cancer.

Authors:  Mark L H Ong; John B Schofield
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  The prognostic yield of biomarkers harvested in chemotherapy-naive stage II colon cancer: can we separate the wheat from the chaff?

Authors:  Martin M Watson; Kjetil Søreide
Journal:  Mol Med       Date:  2016-05-04       Impact factor: 6.354

9.  Use of a computerised decision aid (DA) to inform the decision process on adjuvant chemotherapy in patients with stage II colorectal cancer: development and preliminary evaluation.

Authors:  A Miles; I Chronakis; J Fox; A Mayer
Journal:  BMJ Open       Date:  2017-03-24       Impact factor: 2.692

10.  Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer.

Authors:  Seiichi Shinji; Yoshibumi Ueda; Takeshi Yamada; Michihiro Koizumi; Yasuyuki Yokoyama; Goro Takahashi; Masahiro Hotta; Takuma Iwai; Keisuke Hara; Kohki Takeda; Mikihiro Okusa; Hayato Kan; Eiji Uchida
Journal:  Oncotarget       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.